Rudolph Navari to Organoplatinum Compounds
This is a "connection" page, showing publications Rudolph Navari has written about Organoplatinum Compounds.
Connection Strength
0.014
-
A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a Hoosier Oncology Group study. Cancer Invest. 2004; 22(3):383-8.
Score: 0.014
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.